Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

4-Week Study to Assess the Effect of Alendronate and Vitamin D3 Once Weekly on Fractional Calcium Absorption in Postmenopausal Osteoporotic Women (0217A-230)

This study has been completed.
Information provided by (Responsible Party):
Merck Sharp & Dohme Corp. Identifier:
First received: March 18, 2008
Last updated: December 24, 2014
Last verified: December 2014